C12Y 604/01003
Propionyl-coa carboxylase
Official title: Propionyl-CoA carboxylase (6.4.1.3)
C12Y604/01003 (Propionyl-coa carboxylase) appears on 10 US grants and 23 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 23
- Assignees
- 9
- Inventors
- 57
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 2 |
| 2022 | 1 | 4 |
| 2023 | 1 | 2 |
| 2024 | 1 | 5 |
| 2025 | 2 | 1 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Polynucleotides encoding propionyl-CoA carboxylase alpha and beta subunits for the treatment of propionic acidemia21 Jul 2026US 12,685,785 B2ModernaTX, Inc.
- Gene therapy for treating propionic acidemia21 Jul 2026US 12,686,874 B2Ultragenyx Pharmaceutical Inc.
- Gene therapy for treating propionic acidemia18 Nov 2025US 12,472,268 B2Ultragenyx Pharmaceutical Inc.
- Method for producing sedoheptulose20 May 2025US 12,305,208 B2Nagase & Co., Ltd.
- Bioconversion of short-chain hydrocarbons to fuels and chemicals27 Feb 2024US 11,913,049 B2
- Gene therapy for treating propionic acidemia12 Feb 2026US 2026/0041788 A1Ultragenyx Pharmaceutical Inc.
- Improved gene therapy constructs for the treatment of propionic acidemia caused by mutations in propionyl-coa carboxylase alpha13 Feb 2025US 2025/0049952 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
- Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia26 Sep 2024US 2024/0316165 A1ModernaTX, Inc.
- Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals19 Sep 2024US 2024/0309417 A1
- Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof4 Jul 2024US 2024/0216288 A1ModernaTX, Inc.
Most cited
By later US patents
- Intermediates and surfactants useful in household cleaning and personal care compositions, and methods of making the same10US 8,933,131 B2The Procter & Gamble Company · 2015
- Sequestration of carbon dioxide with hydrogen to useful products2US 9,587,256 B2North Carolina State University · 2017
- Gene therapy for treating propionic acidemia1US 12,472,268 B2Ultragenyx Pharmaceutical Inc. · 2025